Documentation of the Safety and Effectiveness Profile of the IgG Immunoadsorber GLOBAFFIN® in Clinical Routine
Clinical trial NCT04078698 · COMPLETED
Trial details
- NCT number
- NCT04078698
- Sponsor
- Fresenius Medical Care Deutschland GmbH
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-05
- Primary completion
- 2025-05-30
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.